ONWARD® Medical Submits De Novo Application to FDA for its
ONWARD Medical has submitted its De Novo application to the US Food and Drug Administration (FDA) to allow marketing of its breakthrough ARC-EX System. ...
Stay updated with breaking news from Candy Tefertiller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ONWARD Medical has submitted its De Novo application to the US Food and Drug Administration (FDA) to allow marketing of its breakthrough ARC-EX System. ...
FDA clearance would allow the Company to market its breakthrough therapy to improve or restore hand and arm function after spinal cord injury in the USTHIS PRESS RELEASE CONTAINS INSIDE INFORMATION...
LIFT Home study evaluated the safety and feasibility of ARC-EX Therapy in the home setting 100% of subjects completed the study with no reported serious adverse events 97% of therapy sessions
/PRNewswire/ -- Craig Hospital, a world-renowned neurorehabilitation and research hospital for people who have sustained spinal cord and/or brain injuries, has...
The hospital is one of nine rehabilitation hospitals in the U.S. that has earned SCI and TBI Model Systems designations.